MC1R and neoplasm: Moreover, polymorphisms in the extracellular domain can lead to variations in structural conformations, and a truncating mutation in MC1R in the extracellular domains may result in an absence of detectable tumor protein expression.36 As such, antibodies would need to be strategically designed to bind to conserved regions of the extracellular domain which are less affected by genetic variants.